Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) currently poses a threat to human health. 3C-like …

COVID-19 caused by SARS-CoV-2 in late 2019 is still threatening global human health.
Although some vaccines and drugs are available in the market, controlling the spread of the …

This work deals with the synthesis, crystal structure, computational study and antiviral
potential of mixed ligand copper (II) complex [Cu (L)(phen)](1),(where, H 2 L=(Z)-N'-((E)-2 …

In the design and development of therapeutic agents, macromolecules with restricted
structures have stronger competitive edges than linear biological entities since cyclization …

At present, much attention is paid to the use of antimicrobial peptides (AMPs) of natural and
artificial origin to combat pathogens. AMPs have several points that determine their …

This paper presents the design and study of a first-in-class cyclic peptide inhibitor against
the SARS-CoV-2 main protease (M pro). The cyclic peptide inhibitor is designed to mimic the …

Peroxisome proliferator-activated receptor-γ (PPAR-γ) partial agonists or antagonists, also
termed as selective PPAR-γ modulators, are more beneficial than full agonists because they …

A therapy for COVID-19 (Coronavirus Disease 19) caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) remains elusive due to the lack of an effective …

The aim of this study was to synthesize and examine the molecular docking of a Mo (VI)
complex [Mo (dien) O3](1),{N1-[2-(amino) ethyl] ethane-1, 2-diamine}-[tris (oxido)] …

Since December 2019, humanity has faced an important global threat. Many studies have
been published on the origin, structure, and mechanism of action of the SARS-CoV-2 virus …